» Articles » PMID: 24376769

A Large-scale Allosteric Transition in Cytochrome P450 3A4 Revealed by Luminescence Resonance Energy Transfer (LRET)

Overview
Journal PLoS One
Date 2013 Dec 31
PMID 24376769
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Effector-induced allosteric transitions in cytochrome P450 3A4 (CYP3A4) were investigated by luminescence resonance energy transfer (LRET) between two SH-reactive probes attached to various pairs of distantly located cysteine residues, namely the double-cysteine mutants CYP3A4(C64/C468), CYP3A4(C377/C468) and CYP3A4(C64/C121). Successive equimolar labeling of these proteins with the phosphorescent probe erythrosine iodoacetamide (donor) and the near-infrared fluorophore DY-731 maleimide (acceptor) allowed us to establish donor/acceptor pairs sensitive to conformational motions. The interactions of all three double-labeled mutants with the allosteric activators α-naphthoflavone and testosterone resulted in an increase in the distance between the probes. A similar effect was elicited by cholesterol. These changes in distance vary from 1.3 to 8.5 Å, depending on the position of the donor/acceptor pair and the nature of the effector. In contrast, the changes in the interprobe distance caused by such substrates as bromocriptine or 1-pyrenebutanol were only marginal. Our results provide a decisive support to the paradigm of allosteric modulation of CYP3A4 and indicate that the conformational transition caused by allosteric effectors increases the spatial separation between the beta-domain of the enzyme (bearing residues Cys64 and Cys377) and the alpha-domain, where Cys121 and Cys468 are located.

Citing Articles

Midazolam as a Probe for Heterotropic Drug-Drug Interactions Mediated by CYP3A4.

Denisov I, Grinkova Y, McLean M, Camp T, Sligar S Biomolecules. 2022; 12(6).

PMID: 35740978 PMC: 9221276. DOI: 10.3390/biom12060853.


Identification of the contact region responsible for the formation of the homomeric CYP1A2•CYP1A2 complex.

Saha A, Connick J, Reed J, Lott C, Backes W Biochem J. 2021; 478(11):2163-2178.

PMID: 34032264 PMC: 8522333. DOI: 10.1042/BCJ20210269.


Midazolam as a Probe for Drug-Drug Interactions Mediated by CYP3A4: Homotropic Allosteric Mechanism of Site-Specific Hydroxylation.

Denisov I, Grinkova Y, Camp T, McLean M, Sligar S Biochemistry. 2021; 60(21):1670-1681.

PMID: 34015213 PMC: 8857940. DOI: 10.1021/acs.biochem.1c00161.


Correction to "Allosteric Interactions in Human Cytochrome P450 CYP3A4: The Role of Phenylalanine 213".

Denisov I, Grinkova Y, Nandigrami P, Shekhar M, Tajkhorshid E, Sligar S Biochemistry. 2019; 58(24):2796.

PMID: 31181900 PMC: 7528618. DOI: 10.1021/acs.biochem.9b00438.


Allosteric Interactions in Human Cytochrome P450 CYP3A4: The Role of Phenylalanine 213.

Denisov I, Grinkova Y, Nandigrami P, Shekhar M, Tajkhorshid E, Sligar S Biochemistry. 2019; 58(10):1411-1422.

PMID: 30785734 PMC: 7003538. DOI: 10.1021/acs.biochem.8b01268.


References
1.
Davydov D, Baas B, Sligar S, Halpert J . Allosteric mechanisms in cytochrome P450 3A4 studied by high-pressure spectroscopy: pivotal role of substrate-induced changes in the accessibility and degree of hydration of the heme pocket. Biochemistry. 2007; 46(26):7852-64. PMC: 2527461. DOI: 10.1021/bi602400y. View

2.
Amler E, Abbott A, Ball Jr W . Structural dynamics and oligomeric interactions of Na+,K(+)-ATPase as monitored using fluorescence energy transfer. Biophys J. 1992; 61(2):553-68. PMC: 1260269. DOI: 10.1016/S0006-3495(92)81859-3. View

3.
Isin E, Guengerich F . Kinetics and thermodynamics of ligand binding by cytochrome P450 3A4. J Biol Chem. 2006; 281(14):9127-36. DOI: 10.1074/jbc.M511375200. View

4.
Atkins W, Qian H . Stochastic ensembles, conformationally adaptive teamwork, and enzymatic detoxification. Biochemistry. 2011; 50(19):3866-72. PMC: 3092024. DOI: 10.1021/bi200275r. View

5.
Isin E, Guengerich F . Substrate binding to cytochromes P450. Anal Bioanal Chem. 2008; 392(6):1019-30. PMC: 4756639. DOI: 10.1007/s00216-008-2244-0. View